Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

GABAB receptors in glial cells: from physiological regulation to pathological implications.
Imaging progenitor cell differentiation during central nervous system remyelination using an MRI gene reporter.
Generalizable spinal cord multiple sclerosis lesion segmentation across MRI contrasts, protocols, and centers.
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4-IgG-Positive NMOSD.
Depletion of promotes neuroinflammatory attack against myelin in an experimental autoimmune encephalomyelitis mouse model.
Cost-Effectiveness of Dimethyl Fumarate Versus Teriflunomide in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) in Iran.
Microglial PD-1/PD-L1 axis in CNS demyelinating diseases: a dual immunoregulatory perspective.
The clinical significance of S100B, APP, and CHI3L1 in autoimmune GFAP astrocytopathy.
Effects of thoracic manipulation with trigger point therapy on inflammatory cytokine levels in individuals with multiple sclerosis: a pilot study.
Ultrastructural analysis of human uncinate fasciculus with coherent anti-Stokes Raman spectroscopy.
Natalizumab for pediatric multiple sclerosis: a systematic review and meta-analysis.
Sex differences in the development, treatment, and prognosis of multiple sclerosis in Switzerland.
In vivo adenine base editing of mutant Galc gene ameliorates Krabbe disease progression.
Pharmacological modulation of CXCL12/CXCR4/ACKR3 for brain disorders - an overview.
Charting the transition from in vitro gliogenesis to the in vivo maturation of human glial progenitor cells transplanted into the hypomyelinated mouse brain.
C3 and C5 Complement Cascade Activation in Brain Injury and Disease: Molecular Mechanisms, Pathological Roles, and Therapeutic Implications.
The use of baseline risk in cost-effectiveness modelling of competing interventions.
The role of Epstein-Barr virus in multiple sclerosis: From pathogenesis to therapeutic potential.
The impact of the COVID-19 pandemic on the incidence and clinical profiles of Guillain-Barré syndrome in Japan.
Patient experiences with systematically-administered patient-reported outcome measures in multiple sclerosis.
TSPO-PET-measurable neuroinflammation associates with brain atrophy in multiple sclerosis.
Identification of paucinervin D as a natural sphingosine-1-phosphate receptor 1 agonist: Insights from pharmacophore modeling, docking, molecular dynamics simulations, and density functional theory.
Hyperoside accelerates myelin debris clearance by inhibiting signal transducer and activator of transcription 3 phosphorylation in peripheral nerve injury.
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.
Aerobic Exercise Is Associated with Divergent Regulation of Macrophage Migration Inhibitory Factor and Enhanced Remyelination in Experimental Autoimmune Neuritis.

Pages